Gerda Roest

483 total citations
7 papers, 405 citations indexed

About

Gerda Roest is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Gerda Roest has authored 7 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Gerda Roest's work include Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune Cell Function and Interaction (2 papers). Gerda Roest is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune Cell Function and Interaction (2 papers). Gerda Roest collaborates with scholars based in Netherlands, France and Belgium. Gerda Roest's co-authors include Pieter Voorn, Henk J. Groenewegen, Philippe Céruse, I. Bing Tan, Gilles Dolivet, Vincent Vander Poorten, Peter Palmer, C.R. Franks, R. Oskam and Pauline Evers and has published in prestigious journals such as Cancer, Brain Research and European Journal of Cancer.

In The Last Decade

Gerda Roest

7 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerda Roest Netherlands	6	159	108	99	96	87	7	405
David Shine United States	3	141 0.9×	76 0.7×	78 0.8×	71 0.7×	21 0.2×	5	330
Toru Hayakawa Japan	13	81 0.5×	85 0.8×	92 0.9×	77 0.8×	12 0.1×	20	381
Michael Hutzler United States	10	132 0.8×	291 2.7×	32 0.3×	80 0.8×	38 0.4×	15	578
Hung‐Lin Lin Taiwan	11	54 0.3×	96 0.9×	12 0.1×	137 1.4×	102 1.2×	20	515
Peter H. Koo United States	16	177 1.1×	275 2.5×	46 0.5×	32 0.3×	76 0.9×	35	513
Mitsuyuki Takamura Japan	5	62 0.4×	129 1.2×	30 0.3×	139 1.4×	27 0.3×	14	387
Andrea Bianchetti Italy	10	56 0.4×	94 0.9×	25 0.3×	80 0.8×	29 0.3×	16	300
Ulrich Mangold Germany	10	83 0.5×	141 1.3×	27 0.3×	54 0.6×	29 0.3×	15	341
Roberto Micheli Italy	9	81 0.5×	217 2.0×	27 0.3×	22 0.2×	18 0.2×	16	387
Wenjie Wei China	10	114 0.7×	282 2.6×	50 0.5×	68 0.7×	39 0.4×	21	460

Countries citing papers authored by Gerda Roest

Since Specialization

Citations

This map shows the geographic impact of Gerda Roest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerda Roest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerda Roest more than expected).

Fields of papers citing papers by Gerda Roest

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerda Roest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerda Roest. The network helps show where Gerda Roest may publish in the future.

Co-authorship network of co-authors of Gerda Roest

This figure shows the co-authorship network connecting the top 25 collaborators of Gerda Roest. A scholar is included among the top collaborators of Gerda Roest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerda Roest. Gerda Roest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Tan, I. Bing, et al.. (2010). Temoporfin‐mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study. Head & Neck. 32(12). 1597–1604. 89 indexed citations

2.

Stam, Anita G.M., B. Mary E. von Blomberg, Gerda Roest, et al.. (1994). The development of anti-interleukin-2 (IL-2) antibodies in cancer patients treated with recombinant IL-2. European Journal of Cancer. 30(12). 1804–1809. 17 indexed citations

3.

Palmer, Peter, B. Mary E. von Blomberg, Anita G.M. Stam, et al.. (1994). Persistent augmentation of natural-killer-and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance dose. Cancer Immunology Immunotherapy. 39(1). 34–40. 2 indexed citations

4.

Ardizzoni, Andrea, Editta Baldini, Anna Verna, et al.. (1994). Biologic and clinical effects of continuous infusion interleukin-2 in patients with non-small cell lung cancer. Cancer. 73(5). 1353–1360. 27 indexed citations

5.

Palmer, Peter, Jens Atzpodien, Thierry Philip, et al.. (1993). A Comparison of 2 Modes of Administration of Recombinant Interleukin-2: Continuous Intravenous Infusion Alone Versus Subcutaneous Administration plus Interferon Alpha in Patients with Advanced Renal Cell Carcinoma.. PubMed. 8(2). 123–136. 47 indexed citations

6.

Palmer, Peter, Pauline Evers, R. Oskam, et al.. (1992). Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinoma. European Journal of Cancer. 28(6-7). 1038–1044. 56 indexed citations

7.

Voorn, Pieter, Gerda Roest, & Henk J. Groenewegen. (1987). Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions. Brain Research. 412(2). 391–396. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact